1. Home
  2. EHTH vs STTK Comparison

EHTH vs STTK Comparison

Compare EHTH & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eHealth Inc.

EHTH

eHealth Inc.

HOLD

Current Price

$1.51

Market Cap

104.0M

Sector

Finance

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$5.96

Market Cap

275.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EHTH
STTK
Founded
1997
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.0M
275.9M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
EHTH
STTK
Price
$1.51
$5.96
Analyst Decision
Hold
Buy
Analyst Count
3
7
Target Price
$3.33
$7.60
AVG Volume (30 Days)
1.0M
576.6K
Earning Date
01-01-0001
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
71.43
53.02
EPS
N/A
N/A
Revenue
$251,395,000.00
$1,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.18
N/A
P/E Ratio
N/A
N/A
Revenue Growth
45.86
N/A
52 Week Low
$1.20
$0.69
52 Week High
$7.63
$6.27

Technical Indicators

Market Signals
Indicator
EHTH
STTK
Relative Strength Index (RSI) 38.83 71.91
Support Level $1.20 $1.85
Resistance Level $1.93 N/A
Average True Range (ATR) 0.16 0.41
MACD 0.07 0.12
Stochastic Oscillator 46.04 88.39

Price Performance

Historical Comparison
EHTH
STTK

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: